Abstract: In 2001, the U.S. Food and Drug Administration (FDA) launched numerous initiatives to assure the availability of medical products for the treatment of injuries that could be caused by terrorists using biologic, chemical, or nuclear agents.
Publication Year: 2002
Publication Date: 2002-06-01
Language: en
Type: article
Indexed In: ['pubmed']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot